Related Experiment Video
Updated: Jul 10, 2026
10:44
Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
Published on: March 28, 2017
Cytochrome P450 testing for better psychiatric care.
Elizabeth L Pestka1, Ann M Hale, Bonnie L Johnson
1Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN 55905, USA. pestka.elizabeth@mayo.edu
Journal of Psychosocial Nursing and Mental Health Services
|November 10, 2007
Summary
Genetic testing for CYP2D6 and CYP2C19 variations can guide psychiatric medication dosages. Nurses require genetics knowledge to advocate for patients undergoing cytochrome P450 testing.
Area of Science:
- Pharmacogenomics
- Clinical Genetics
- Nursing Education
Background:
- Cytochrome P450 (CYP450) enzymes, specifically CYP2D6 and CYP2C19, play a crucial role in metabolizing many psychiatric medications.
- Individual variations in CYP450 genes can significantly impact drug efficacy and patient response, leading to potential adverse effects or treatment failure.
- Integrating genetic information into clinical practice is essential for personalized medicine in mental health.
Purpose of the Study:
- To highlight the emerging role of CYP2D6 and CYP2C19 genotyping in psychiatric pharmacotherapy.
- To emphasize the necessity for nurses to develop core competencies in genetics and genomics, particularly concerning pharmacogenetic testing.
- To outline the nursing role in patient advocacy, including identifying suitable candidates for genetic testing, obtaining informed consent, and patient education.
Main Methods:
- Review of current literature on CYP450 genetic testing in psychiatry.
- Analysis of essential nursing competencies in genetics and genomics.
- Discussion of the practical application of pharmacogenetic testing in clinical mental health settings.
Main Results:
- CYP2D6 and CYP2C19 genotyping offers a valuable tool for optimizing psychiatric drug selection and dosage.
- Nurses are pivotal in the implementation of pharmacogenetic testing, requiring specialized knowledge and skills.
- Understanding genetic variations allows nurses to better advocate for patients, ensuring informed consent and appropriate education.
Conclusions:
- Pharmacogenetic testing for CYP2D6 and CYP2C19 variations is a key advancement in personalized psychiatric care.
- Nurses must be equipped with genetic and genomic competencies to effectively support patients undergoing this testing.
- Enhanced nursing knowledge facilitates informed decision-making and improves patient outcomes in psychopharmacology.
Related Concept Videos
01:28Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...